Arcturus Therapeutics
ARCT
$26.63
Share price
0.30%
Change (1 day)
1.95%
Change (1 year)
Arcturus Therapeutics (ARCT) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $0.15 B
According to Arcturus Therapeutics 's latest financial reports the company's total liabilities are $0.15 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Arcturus Therapeutics - Total liabilities on balance sheet (from 2012 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $0.15 B | -16.21% |
| 2022-12-31 | $0.18 B | 9.4% |
| 2021-12-31 | $0.16 B | 106% |
| 2020-12-31 | $79.9 M | 41.8% |
| 2019-12-31 | $56.35 M | 84.42% |
| 2018-12-31 | $30.55 M | 67.61% |
| 2017-12-31 | $18.23 M | 49.93% |
| 2016-12-31 | $12.15 M | 416.96% |
| 2015-12-31 | $2.35 M | -0.97% |
| 2014-12-31 | $2.37 M | 45.17% |
| 2013-12-31 | $1.63 M | 113.02% |
| 2012-12-31 | $0.76 M | 250.68% |
| 2011-12-31 | $0.21 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | $3.14 M | -97.91% | Bahamas |
 NRC Health
NRC | $73.48 M | -51.30% | 🇺🇸 USA |